231 related articles for article (PubMed ID: 33403869)
21. Results of a nationwide survey of Japanese pharmacists regarding the application of pharmacogenomic testing in precision medicine.
Tsuji D; Saito Y; Mushiroda T; Miura M; Hira D; Terada T
J Clin Pharm Ther; 2021 Jun; 46(3):649-657. PubMed ID: 33555613
[TBL] [Abstract][Full Text] [Related]
22. Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing.
Smith DM; Namvar T; Brown RP; Springfield TB; Peshkin BN; Walsh RJ; Welsh JC; Levin B; Brandt N; Swain SM
Pharmacogenomics; 2020 Oct; 21(15):1085-1094. PubMed ID: 32969759
[No Abstract] [Full Text] [Related]
23. Providers' perspectives on the clinical utility of pharmacogenomic testing in pediatric patients.
Liko I; Lee YM; Stutzman DL; Blackmer AB; Deininger KM; Reynolds AM; Aquilante CL
Pharmacogenomics; 2021 Apr; 22(5):263-274. PubMed ID: 33657875
[No Abstract] [Full Text] [Related]
24. Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology.
Shriver SP; Adams D; McKelvey BA; McCune JS; Miles D; Pratt VM; Ashcraft K; McLeod HL; Williams H; Fleury ME
J Clin Oncol; 2024 Apr; 42(10):1181-1192. PubMed ID: 38386947
[TBL] [Abstract][Full Text] [Related]
25. QPGx-CARES: Qatar pharmacogenetics clinical applications and research enhancement strategies.
Abdel-Latif R; Badji R; Mohammed S; Al-Muftah W; Mbarek H; Darwish D; Assaf D; Al-Badriyeh D; Elewa H; Afifi N; Masoodi NA; Omar AS; Al Suwaidi J; Bujassoum S; Al Hail M; Ismail SI; Althani A
Clin Transl Sci; 2024 Jun; 17(6):e13800. PubMed ID: 38818903
[TBL] [Abstract][Full Text] [Related]
26. The challenges of implementing pharmacogenomic testing in the clinic.
Moyer AM; Caraballo PJ
Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
[TBL] [Abstract][Full Text] [Related]
27. Patient perspectives following pharmacogenomics results disclosure in an integrated health system.
Lemke AA; Hulick PJ; Wake DT; Wang C; Sereika AW; Yu KD; Glaser NS; Dunnenberger HM
Pharmacogenomics; 2018 Mar; 19(4):321-331. PubMed ID: 29469671
[TBL] [Abstract][Full Text] [Related]
28. Pre-emptive pharmacogenomics implementation among polypharmacy patients 65 years old and older: a clinical pilot.
Uber R; Hayduk VA; Pradhan A; Ward T; Flango A; Graham J; Wright EA
Pharmacogenomics; 2023 Dec; 24(18):915-920. PubMed ID: 37965783
[No Abstract] [Full Text] [Related]
29. Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.
Nagy M; Attya M; Patrinos GP
Pharmacogenomics; 2020 Nov; 21(17):1247-1264. PubMed ID: 33124490
[TBL] [Abstract][Full Text] [Related]
30. Description of Pharmacogenomic Testing Among Patients Admitted to the Intensive Care Unit After Cardiovascular Surgery.
Peterson PE; Nicholson WT; Moyer AM; Arendt CJ; Smischney NJ; Seelhammer TG; Krecke CA; Haney RM; Yaw EJ; Chlan LL
J Intensive Care Med; 2021 Nov; 36(11):1281-1285. PubMed ID: 32734840
[TBL] [Abstract][Full Text] [Related]
31. Individualizing pharmacogenomic test results in the context of the microbiome.
Haga SB
Per Med; 2020 Nov; 17(6):459-468. PubMed ID: 33026284
[TBL] [Abstract][Full Text] [Related]
32. Clinical Trial Designs to Support Clinical Utility of Pharmacogenomic Testing.
Drozda K; Pacanowski MA
Pharmacotherapy; 2017 Sep; 37(9):1000-1004. PubMed ID: 28605049
[TBL] [Abstract][Full Text] [Related]
33. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL
J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514
[TBL] [Abstract][Full Text] [Related]
34. Variant discovery using next-generation sequencing and its future role in pharmacogenetics.
Russell LE; Schwarz UI
Pharmacogenomics; 2020 May; 21(7):471-486. PubMed ID: 32338137
[TBL] [Abstract][Full Text] [Related]
35. Pharmacogenomics cascade testing (PhaCT): a novel approach for preemptive pharmacogenomics testing to optimize medication therapy.
Roosan D; Hwang A; Roosan MR
Pharmacogenomics J; 2021 Feb; 21(1):1-7. PubMed ID: 32843688
[TBL] [Abstract][Full Text] [Related]
36. Stakeholder perspectives of the clinical utility of pharmacogenomic testing in solid organ transplantation.
Deininger KM; Tran JN; Tsunoda SM; Young GK; Lee YM; Anderson HD; Page Ii RL; Hirsch JD; Aquilante CL
Pharmacogenomics; 2019 Dec; 20(18):1291-1302. PubMed ID: 31755847
[No Abstract] [Full Text] [Related]
37. Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.
Hess GP; Fonseca E; Scott R; Fagerness J
Genet Res (Camb); 2015 Jun; 97():e13. PubMed ID: 26030725
[TBL] [Abstract][Full Text] [Related]
38. Assessing feasibility of delivering pharmacogenetic testing in a community pharmacy setting.
Haga SB; Moaddeb J; Mills R; Voora D
Pharmacogenomics; 2017 Mar; 18(4):327-335. PubMed ID: 28244804
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline.
Miscio G; Paroni G; Bisceglia P; Gravina C; Urbano M; Lozupone M; Piccininni C; Prisciandaro M; Ciavarella G; Daniele A; Bellomo A; Panza F; Di Mauro L; Greco A; Seripa D
Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):751-765. PubMed ID: 31512953
[No Abstract] [Full Text] [Related]
40. Clinical dashboard development and use for academic detailing in the U.S. Department of Veterans Affairs.
Lau MK; Bounthavong M; Kay CL; Harvey MA; Christopher MLD
J Am Pharm Assoc (2003); 2019; 59(2S):S96-S103.e3. PubMed ID: 30713078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]